Biotech

All Articles

Sanofi pays out $110M upfront for late-stage radioligand therapy

.Sanofi has brought in an overdue entrance to the radioligand event, paying one hundred thousand eur...

F 2G increases $100M for second try to get new antifungal to market

.After F2G's first effort to acquire a brand-new course of antifungal to market was derailed due to ...

Moderna targets $1.1 B in R&ampD spending slices, falls 5 courses amid earnings pressures

.Moderna has vowed to reduce R&ampD investing through $1.1 billion by 2027. The selection to retract...

Sanofi's $80M bet on Key dystrophy drug ends in period 3 go bust

.Simply four months after Sanofi bet $80 million in ahead of time cash money on Fulcrum Therapies' l...

Oncternal assets drains 60% amidst cutbacks, trial firings

.Cancer business Oncternal Therapeutics is actually folding all its medical tests and giving up work...

Roche is actually supporting out chances that its own injectable being overweight possibility could eventually illustrate 25% effective weight loss in late-stage test

.Roche is holding out hopes that its injectable weight problems prospect might eventually display 25...

Novo Nordisk hails 'impressive' weight-loss result for dual-acting dental medicine in very early test

.Novo Nordisk has lifted the lid on a stage 1 test of its dental amylin and also GLP-1 receptor co-a...

AbbVie takes legal action against BeiGene over blood stream cancer medicine classified information

.Just a handful of quick full weeks after gaining an FDA Fast Track tag for its own investigational ...

Lilly supplies one-two hit along with 2nd tranche of positive data on regular blood insulin applicant

.Shortly after a positive records reduce for Eli Lilly's efsitora alfa, the Indianapolis-based firm ...

BridgeBio cuts genetics treatment budget plan as medical data let down

.BridgeBio Pharma is lowering its genetics therapy spending plan and drawing back coming from the me...